/PHLI

PHLI Stock - PacificHealth Laboratories, Inc.

Q: What is the analyst price target for PHLI?

Analyst price target information is not currently available for PHLI.

Q: What is PHLI's market cap?

Market capitalization information is not currently available for PHLI.

Consumer Defensive|Household & Personal Products|OTC

$0.00+9900.00%

+$0.00 (+9900.00%) • Feb 11

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PHLI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2007

FY2008

FY2009

FY2010

FY2011

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-329.07

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2011	FY2010	FY2009	FY2008	FY2007
Revenue	$6.91M	$7.20M	$8.00M	$7.24M	$7.43M
Gross Profit	$2.99M	$3.16M	$3.22M	$3.02M	$2.54M
Gross Margin	43.2%	43.9%	40.3%	41.8%	34.2%
Operating Income	$-474,218	$-760,355	$-1,940,587	$-2,039,756	$-1,360,741
Net Income	$-486,311	$-761,422	$-1,676,124	$-1,994,353	$-1,276,059
Net Margin	-7.0%	-10.6%	-21.0%	-27.6%	-17.2%
EPS	$-0.02	$-0.05	$-0.11	$-0.15	$-0.10

Company Overview

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.

Visit Website

Earnings History & Surprises

PHLI

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2012	Nov 6, 2012	—	—	—	—

Frequently Asked Questions about PHLI

What is PHLI's current stock price?

PacificHealth Laboratories, Inc. (PHLI) is currently trading at $0.00 per share. The stock has moved +9900.00% today.

What is the analyst price target for PHLI?

No analyst price targets are currently available for this stock.

What sector is PacificHealth Laboratories, Inc. in?

PacificHealth Laboratories, Inc. operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the OTC exchange.

What is PHLI's market cap?

PacificHealth Laboratories, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PHLI pay dividends?

No, PacificHealth Laboratories, Inc. does not currently pay a dividend to shareholders.